Microglia-mediated inflammatory response

The microglia-mediated inflammatory response, commonly referred to as neuroinflammation, is a complex biological process involving the activation of the resident macrophages of the central nervous system (CNS). Microglia play a dual role in the brain: they provide essential homeostatic support and immune surveillance, but chronic or excessive activation leads to the release of neurotoxic factors such as pro-inflammatory cytokines, reactive oxygen species, and proteases (Colonna & Butovsky, 2017, Immunity). This sustained inflammatory state is a key driver of neuronal damage and disease progression in neurodegenerative conditions like Alzheimer's and Parkinson's disease (Heneka et al., 2015, Nature). Therapeutic interventions targeting this response focus on modulating microglial phenotypes rather than broad suppression, aiming to enhance phagocytic clearance of debris while dampening toxic signaling (Leng & Edison, 2021, Nature Reviews Neurology). Current pharmacological approaches include the use of CSF1R inhibitors to regulate microglial density and NLRP3 inflammasome inhibitors to prevent the maturation of inflammatory cytokines like IL-1beta.

Other names

NeuroinflammationMicroglial activationMicrogliosisCNS inflammatory response

Modulation of microglial polarization from pro-inflammatory (M1-like) to anti-inflammatory (M2-like) states; inhibition of the NLRP3 inflammasome; blockade of CSF1R to deplete or reprogram microglia; antagonism of P2X7 receptors to reduce IL-1beta release.